High neoantigens stimulate the increase of tumor-infiltrating lymphocytes (TILs), and accumulated TILs can be counterbalanced by the overexpression of immune checkpoint regulators, such as PD-L1 and PD-1 (43, 44). The gene discussed is CD274; the disease is neoplasm.